Bio-Rad Laboratories Inc (STU:BUWA)
€ 344.3 4.8 (1.41%) Market Cap: 9.37 Bil Enterprise Value: 9.16 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 75/100

Bio Rad Laboratories Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 12:30AM GMT
Release Date Price: €397.6 (-0.85%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Hi, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team with JPMorgan. Today, I have Norman Schwartz from the Bio-Rad team. This session will be 40 minutes. We'll start off with the standard 20 minutes of management's presentation, followed by 20 minutes of Q&A.

If you're listening to this via the webcast, feel free to submit a question online through the portal. Otherwise, if you're in person, raise your hand, and we have mic runners throughout the room that can get you a microphone. Norman? Thank you.

Norman D. Schwartz
Bio-Rad Laboratories, Inc. - Chairman, CEO & President

Okay. Great. Thank you. Okay. Well, thank you all for joining us here today. It does feel great to be back here in person after several years in 3 dimensions. Since it has been a few years, I thought I'd take kind of the first part of this to refresh everybody on Bio-Rad and what we've accomplished over the last few years and then show you a little bit about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot